Literature DB >> 9718097

Beneficial effect of ischemic preconditioning on Ca2+ paradox in the rat heart.

K Kawabata1, M Osada, T Netticadan, N S Dhalla.   

Abstract

The effect of ischemic preconditioning (IP; 3 min ischemia plus 3 min reperfusion) on the recovery of cardiac function after Ca2+ depletion was investigated. Isolated rat hearts were subjected to different cycles of IP episodes followed by Ca2+ free perfusion and repletion. Perfusion of control hearts with Ca2+ free medium for 5 min followed by repletion of Ca2+ for 30 min resulted in a marked decrease in the left ventricular (LV) developed pressure and an increase in LV end-diastolic pressure (Ca2+ paradox). The depressed function due to Ca2+ paradox recovered with three cycles of IP. Myoglobin release during Ca2+ repletion also decreased significantly by three cycles of IP. The beneficial effects of IP were also evident when the hearts were subjected to a mild form of Ca2+ paradox involving 3 min Ca2+ depletion. The protective effect rendered by IP disappeared when 10 microM of 8-(p-sulfophenyl)-theophylline, adenosine antagonist was perfused for 10 min before IP. These results suggest that IP exerts beneficial effects on Ca2+ paradox which may be mediated by adenosine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9718097     DOI: 10.1016/s0024-3205(98)00319-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  The role of the rat sarcoplasmic reticulum Ca2+-ATPase promoter in myocardial ischemia-preconditioning.

Authors:  Nengfeng Zhang; Baohua Zhu
Journal:  Mol Cell Biochem       Date:  2010-01       Impact factor: 3.396

2.  Myosin heavy chain and cardiac troponin T damage is associated with impaired myofibrillar ATPase activity contributing to sarcomeric dysfunction in Ca2+-paradox rat hearts.

Authors:  Árpád Kovács; Judit Kalász; Enikő T Pásztor; Attila Tóth; Zoltán Papp; Naranjan S Dhalla; Judit Barta
Journal:  Mol Cell Biochem       Date:  2017-02-17       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.